Deficiency of the Housekeeping Gene Hypoxanthine–Guanine Phosphoribosyltransferase (HPRT) Dysregulates Neurogenesis  Ghiabe-Henri Guibinga, Stephen Hsu,

Slides:



Advertisements
Similar presentations
Molecular Therapy - Nucleic Acids
Advertisements

Man's Best Friend: Utilizing Naturally Occurring Tumors in Dogs to Improve Chimeric Antigen Receptor T-cell Therapy for Human Cancers  Melinda Mata, Stephen.
Foxa2: The Rise and Fall of Dopamine Neurons
Volume 78, Issue 6, Pages (June 2013)
Volume 9, Issue 5, Pages (November 2011)
Z. Zhang, Y. Kang, Z. Zhang, H. Zhang, X. Duan, J. Liu, X. Li, W. Liao 
Volume 6, Issue 4, Pages (April 2010)
162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo
Molecular Therapy - Nucleic Acids
Endocannabinoids Control the Induction of Cerebellar LTD
Direct Conversion of Skin Cells into Blood: Alchemy or Science?
Differential Modulation of Cardiac Ca2+ Channel Gating by β-Subunits
Iman M Shammat, Sharona E Gordon  Neuron 
Volume 1, Issue 5, Pages (November 2013)
Volume 16, Issue 5, Pages (May 1996)
Volume 21, Issue 2, Pages e7 (August 2017)
K. Bielefeldt, N. Ozaki, G.F. Gebhart  Gastroenterology 
Volume 19, Issue 10, Pages (October 2011)
Volume 9, Issue 4, Pages (November 2014)
Volume 29, Issue 2, Pages (August 2008)
Unitary Conductance Variation in Kir2
Posttranslational Regulation of Ca2+-Activated K+ Currents by a Target-Derived Factor in Developing Parasympathetic Neurons  Priya Subramony, Sanja Raucher,
Pacemaking by HCN Channels Requires Interaction with Phosphoinositides
Development and Dynamic Regulation of Mitochondrial Network in Human Midbrain Dopaminergic Neurons Differentiated from iPSCs  Du Fang, Yu Qing, Shijun.
Volume 22, Issue 11, Pages (November 2015)
Volume 2, Issue 2, Pages (February 2014)
Volume 19, Issue 11, Pages (November 2011)
724. Blood-Derived Endothelial Progenitor Cells Can Be Isolated With a Novel Method of Diluted Whole Blood Incubation with AMD3100-Induced Mobilization.
Volume 21, Issue 10, Pages (December 2017)
Conversion of Fibroblasts to Neural Cells by p53 Depletion
Molecular Therapy - Methods & Clinical Development
Volume 9, Issue 2, Pages (August 2011)
Volume 23, Issue 3, Pages (July 1999)
Raymond T Bartus, Marc S Weinberg, R. Jude Samulski  Molecular Therapy 
Volume 12, Issue 6, Pages (August 2015)
Characterization of the Dopamine Defect in Primary Cultures of Dopaminergic Neurons from Hypoxanthine Phosphoribosyltransferase Knockout Mice  Doug W.
Dario Brambilla, David Chapman, Robert Greene  Neuron 
Molecular Therapy  Volume 7, Issue 5, (May 2003) DOI: /S (16)
Volume 9, Issue 5, Pages (November 2017)
Molecular Therapy - Nucleic Acids
Volume 70, Issue 1, Pages (April 2011)
Koen Vervaeke, Hua Hu, Lyle J. Graham, Johan F. Storm  Neuron 
Transdetermination: A New Trend in Cellular Reprogramming
Volume 18, Issue 5, Pages (May 1997)
Molecular Therapy  Volume 18, Pages S260-S261 (May 2010) DOI: /S (16)
In This Issue Molecular Therapy Volume 16, Issue 4, (April 2008)
SiRNA knockdown of dynein IC2-C recovered the inhibition of neurite outgrowth in NF1-KD PC12 cells. siRNA knockdown of dynein IC2-C recovered the inhibition.
Thrombospondin-1 Plays a Critical Role in the Induction of Hair Follicle Involution and Vascular Regression During the Catagen Phase  Kiichiro Yano, Michael.
521. AAV Immunotherapy Induces Functional Antigen Specific Regulatory T-Cells to a Neuroantigen: A Potential Treatment for MS  Brad E. Hoffman  Molecular.
Development and Dynamic Regulation of Mitochondrial Network in Human Midbrain Dopaminergic Neurons Differentiated from iPSCs  Du Fang, Yu Qing, Shijun.
Volume 2, Issue 3, Pages (March 2014)
Volume 9, Issue 2, Pages (August 2017)
740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells    Molecular Therapy  Volume 20, Pages S285-S286.
Pitx3-GFP+ cells exhibit functional neuron-like electrophysiological properties. Pitx3-GFP+ cells exhibit functional neuron-like electrophysiological properties.
Molecular Therapy  Volume 21, Pages S247-S248 (May 2013)
Ping Zhong, Zhixing Hu, Houbo Jiang, Zhen Yan, Jian Feng  Cell Reports 
Molecular Therapy - Nucleic Acids
86. A Highly Compact Epitope-Based Marker Suicide Gene for Safer and Easier Adoptive T-Cell Gene Therapy    Molecular Therapy  Volume 20, Pages S35-S36.
Volume 11, Issue 9, Pages (June 2015)
Volume 38, Issue 1, Pages (April 2010)
Volume 14, Issue 2, Pages (April 2004)
Sydney Cash, Yang Dan, Mu-ming Poo, Robert Zucker  Neuron 
Volume 18, Issue 8, Pages (August 2010)
Taro Ishikawa, Yoshinori Sahara, Tomoyuki Takahashi  Neuron 
Molecular Therapy - Nucleic Acids
Volume 66, Issue 2, Pages (April 2010)
Volume 57, Issue 6, Pages (March 2008)
V.S. Eckle, U. Rudolph, B. Antkowiak, C. Grasshoff 
Arati Sridharan, Chetan Patel, Jit Muthuswamy 
Postsynaptic Complexin Controls AMPA Receptor Exocytosis during LTP
Presentation transcript:

Deficiency of the Housekeeping Gene Hypoxanthine–Guanine Phosphoribosyltransferase (HPRT) Dysregulates Neurogenesis  Ghiabe-Henri Guibinga, Stephen Hsu, Theodore Friedmann  Molecular Therapy  Volume 18, Issue 1, Pages 54-62 (January 2010) DOI: 10.1038/mt.2009.178 Copyright © 2010 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 Expression of transcription factors required for specification and development of dopaminergic neurons, as determined by quantitative PCR. Cellular RNA purified from wild-type (open bars) and HPRT-deficient (closed bars) NT2 cells at 0 and 18 days of retinoic acid differentiation were examined by quantitative PCR for the transcription factors (a) Lmx1a, (b) Msx1, (c) Ngn2, (d) Mash1, (e) Nurr1, (f) Pitx3, and (g) FoxA1. * represents statistical significance between wild-type and HPRT-deficient cells (Student's t-test). bHLH, basic helix-loop-helix; HPRT, hypoxanthine–guanine phosphoribosyltransferase; mDA, midbrain dopaminergic neuron. Molecular Therapy 2010 18, 54-62DOI: (10.1038/mt.2009.178) Copyright © 2010 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 2 Expression of transcription factors required for pan-neuronal development, as determined by quantitative PCR. Wild-type (open bars) and HPRT-deficient (closed bars). (a) Lmx1b, (b) Ngn1, (c) NeuroD, and (d) FoxA2. Gene expression on day 0 was at or near background levels for all four genes. * represents statistical significance between wild-type and HPRT-deficient cells (Student's t-test). bHLH, basic helix-loop-helix. Molecular Therapy 2010 18, 54-62DOI: (10.1038/mt.2009.178) Copyright © 2010 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 3 Quantitative PCR analysis of gene expression of dopamine marker genes in undifferentiated (day 0) and differentiated (day 21) NT2 cells. Cellular RNA purified from wild-type (open bars) and HPRT-deficient (closed bars) NT2 cells at 0 and 21 days of retinoic acid differentiation was examined by quantitative PCR for each of the dopaminergic markers. * represents statistically significant difference between wild-type and HPRT-deficient cells (Student's t-test). AADC, aromatic L-amino-acid decarboxylase; TH, tyrosine hydroxylase. Molecular Therapy 2010 18, 54-62DOI: (10.1038/mt.2009.178) Copyright © 2010 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 4 Analysis of neurite outgrowth in wild-type and HPRT-deficient NT2-derived neurons. (a) and (b) represent phase-contrast images of wild-type and HPRT-knockdown cells at 49 days, demonstrating blunted neurite outgrowth and rounded morphology of the latter cells. (c) Quantitation of neurite lengths in wild-type (open bars) and HPRT-knockdown cells (closed bars) at both 21 and 49 days. (d) Histogram of the frequency distribution of neurites in wild-type (open bars) and HPRT-deficient (closed bars) demonstrating a skewed distribution toward the shorter lengths in HPRT-deficient cells, especially evident at 49 days. The frequency distribution of neurite lengths was quantitated by MetaMorph imaging and morphometric and Matrox Intellicam software (see Materials and Methods). HPRT-Kd, hypoxanthine–guanine phosphoribosyltransferase-knockdown. * represents statistical significance between wild-type and HPRT-deficient cells (Student's t-test). Molecular Therapy 2010 18, 54-62DOI: (10.1038/mt.2009.178) Copyright © 2010 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 5 Analysis of voltage-gated Na+ currents in wild-type and HPRT-deficient NT2-neuronal cells by whole cell patch clamp recordings. (a) Na+ currents (upper traces) were evoked by incremental 20 mV voltage steps (−60 to +40 mV, bottom traces) from a holding potential of −90 mV. The evoked Na+ currents could be totally abolished by the presence of 0.3 µmol/l TTX (middle traces). (b) The current to voltage (I–V) relation of the evoked Na+ currents was shown for wild-type (closed symbols) and HPRT-deficient (open symbols) NT2 cells on day 49 of RA-induced differentiation. The maximum current was obtained at −20 mV for both cell types. (c) Maximum Na+ currents were measured at 21 (open bars) and 49 days (filled bars) of RA induction in wild-type and HPRT-deficient NT2-neuronal cells. There were no reproducibly significant differences between the wild-type and HPRT-knockdown cells (n = 31). HPRT-Kd, hypoxanthine–guanine phosphoribosyltransferase-knockdown; TTX, tetrodotoxin. Molecular Therapy 2010 18, 54-62DOI: (10.1038/mt.2009.178) Copyright © 2010 The American Society of Gene & Cell Therapy Terms and Conditions